Autogenous Mesenchymal Stem Cell Culture-Derived Signalling Molecules as Enhancers of Bone Formation in Bone Grafting

Clinical trial NCT04998058 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04998058
Sponsor: Pontificia Universidade Católica do Rio Grande do Sul
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bone Loss, Osteoclastic Bone Loss, Alveolar Alveolar Bone Loss Alveolar Bone Atrophy Grafting Bone

Start date: 2025-12-15
Primary completion: 2026-08-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.